The Phentermine market is a subset of the Anti-Obesity Drugs market, which is composed of pharmaceuticals used to treat obesity. Phentermine is a sympathomimetic amine, which is an appetite suppressant that works by stimulating the hypothalamus gland and affecting certain neurotransmitters to decrease appetite. It is typically prescribed for short-term use, as it can be habit-forming and has potential for abuse. Common side effects include dry mouth, insomnia, and increased heart rate. The Anti-Obesity Drugs market is composed of a variety of products, including Phentermine, Orlistat, Lorcaserin, and Bupropion. These products are used to treat obesity, either alone or in combination with lifestyle changes such as diet and exercise. Some companies in the Phentermine market include KVK Tech, Inc., Actavis, Inc., Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
